Pathogenesis of Atherosclerosis
Erling Falk, MD, PhD*
Department of Cardiology, Aarhus University Hospital (Skejby), Aarhus, Denmark.
Manuscript received June 16, 2005;
revised manuscript received September 12, 2005,
accepted September 19, 2005.
* Reprint requests and correspondence: Dr. Erling Falk, Department of Cardiology, Aarhus University Hospital (Skejby), Brendstrupgaardsvej, DK-8200 Aarhus N, Denmark. (Email: erling.falk{at}ki.au.dk).
Atherosclerosis is a multifocal, smoldering, immunoinflammatory disease of medium-sized and large arteries fuelled by lipids. Endothelial cells, leukocytes, and intimal smooth muscle cells are the major players in the development of this disease. The most devastating consequences of atherosclerosis, such as heart attack and stroke, are caused by superimposed thrombosis. Therefore, the vital question is not why atherosclerosis develops but rather why atherosclerosis, after years of indolent growth, suddenly becomes complicated with luminal thrombosis. If thrombosis-prone plaques could be detected and thrombosis averted, atherosclerosis would be a much more benign disease. Approximately 76% of all fatal coronary thrombi are precipitated by plaque rupture. Plaque rupture is a more frequent cause of coronary thrombosis in men ( 80%) than in women ( 60%). Ruptured plaques are characterized by a large lipid-rich core, a thin fibrous cap that contains few smooth muscle cells and many macrophages, angiogenesis, adventitial inflammation, and outward remodeling. Plaque rupture is the most common cause of coronary thrombosis. Ruptured plaques and, by inference, rupture-prone plaques have characteristic pathoanatomical features that might be useful for their detection in vivo by imaging. This article describes the pathogenesis of atherosclerosis, how it begets thrombosis, and the possibility to detect thrombosis-prone plaques and prevent heart attack.
|
Abbreviations and Acronyms
| | HDL = high-density lipoprotein | | LDL = low-density lipoprotein | | MCP-1 = monocyte chemotactic protein-1 | | NOS = nitric oxide synthase | | VCAM-1 = vascular cell adhesion molecule-1 |
|
This article has been cited by other articles:

|
 |

|
 |
 
M Ni, W Q Chen, and Y Zhang
Animal models and potential mechanisms of plaque destabilisation and disruption
Heart,
September 1, 2009;
95(17):
1393 - 1398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wagenknecht, B. Wasserman, L. Chambless, J. Coresh, A. Folsom, T. Mosley, C. Ballantyne, R. Sharrett, and E. Boerwinkle
Correlates of Carotid Plaque Presence and Composition as Measured by MRI: The Atherosclerosis Risk in Communities Study
Circ Cardiovasc Imaging,
July 1, 2009;
2(4):
314 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Moreno, J. Sanz, and V. Fuster
Promoting Mechanisms of Vascular Health: Circulating Progenitor Cells, Angiogenesis, and Reverse Cholesterol Transport
J. Am. Coll. Cardiol.,
June 23, 2009;
53(25):
2315 - 2323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Garcia-Garcia, P. W. Serruys, G. S. Mintz, S. Saito, V. Klaus, P. Margolis, S. Carlier, D. Goedhart, and R. Schwartz
Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries a report from the global intravascular radiofrequency data analysis registry.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Brodoefel, C. Burgstahler, A. Sabir, C.-S. Yam, F. Khosa, C. D. Claussen, and M. E. Clouse
Coronary Plaque Quantification by Voxel Analysis: Dual-Source MDCT Angiography Versus Intravascular Sonography
Am. J. Roentgenol.,
March 1, 2009;
192(3):
W84 - W89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Foglieni, F. Maisano, L. Dreas, A. Giazzon, G. Ruotolo, E. Ferrero, L. Li Volsi, S. Coli, G. Sinagra, B. Zingone, et al.
Mild inflammatory activation of mammary arteries in patients with acute coronary syndromes
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2831 - H2837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Doran, N. Meller, and C. A. McNamara
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
812 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Diringer, B. E. Skolnick, S. A. Mayer, T. Steiner, S. M. Davis, N. C. Brun, and J. P. Broderick
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage
Stroke,
March 1, 2008;
39(3):
850 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Knapp, J. E. Ramsey, S.-X. Wang, A. R. Strauch, and R. J. Kelm Jr.
Structure-Function Analysis of Mouse Pur II: CONFORMATION ALTERING MUTATIONS DISRUPT SINGLE-STRANDED DNA AND PROTEIN INTERACTIONS CRUCIAL TO SMOOTH MUSCLE {alpha}-ACTIN GENE REPRESSION
J. Biol. Chem.,
December 7, 2007;
282(49):
35899 - 35909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tello-Montoliu, F. Marin, J. Patel, V. Roldan, L. Mainar, V. Vicente, F. Sogorb, and G. Y.H. Lip
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis
Eur. Heart J.,
December 2, 2007;
28(24):
3006 - 3011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Punjabi, B. A. Beamer, A. Jain, M. E. Spencer, and N. Fedarko
Elevated Levels of Neopterin in Sleep-Disordered Breathing
Chest,
October 1, 2007;
132(4):
1124 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dalager, W. P. Paaske, I. Bayer Kristensen, J. Marsvin Laurberg, and E. Falk
Artery-Related Differences in Atherosclerosis Expression: Implications for Atherogenesis and Dynamics in Intima-Media Thickness
Stroke,
October 1, 2007;
38(10):
2698 - 2705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Falk, S. M. Schwartz, Z. S. Galis, and M. E. Rosenfeld
Putative Murine Models of Plaque Rupture
Arterioscler Thromb Vasc Biol,
April 1, 2007;
27(4):
969 - 972.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Thomas, G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby
Genomics of Foam Cells and Nonfoamy Macrophages From Rabbits Identifies Arginase-I as a Differential Regulator of Nitric Oxide Production
Arterioscler Thromb Vasc Biol,
March 1, 2007;
27(3):
571 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tsimikas, M. Aikawa, F. J. Miller Jr, E. R. Miller, M. Torzewski, S. R. Lentz, C. Bergmark, D. D. Heistad, P. Libby, and J. L. Witztum
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression
Arterioscler Thromb Vasc Biol,
January 1, 2007;
27(1):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Muller, A. Tawakol, S. Kathiresan, and J. Narula
New opportunities for identification and reduction of coronary risk treatment of vulnerable patients, arteries, and plaques.
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8 Suppl):
C2 - C6.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|